NCT00768677
Completed
Not Applicable
Open-Label Study of Topiramate for Binge Eating Disorder and Bulimia Nervosa Among Adolescents
The Zucker Hillside Hospital1 site in 1 countryJuly 2003
Drugstopiramate
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Eating Disorders
- Sponsor
- The Zucker Hillside Hospital
- Locations
- 1
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
This is a study of topiramate to see whether topiramate decreases binge eating behavior among adolescents and young adults. The investigators did also checked whether topiramate affected cognitive function or not.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects (aged 12 to 23) were included if they
- •Met the criteria of bulimia nervosa or eating disorder NOS with binge-eating behavior in DSM-IV-TR,
- •Had weight \> or = 100th % of expected body weight for their age,
- •Engaged in binge eating at least once a week for 9 out of the 12 weeks prior to the study entry, and
- •Were judged by a clinician to be stable enough to be treated for their psychiatric condition as an outpatient (i.e, no acute suicidality, hallucination, unstable vital signs or persistently abnormal laboratory results due to eating disorder).
Exclusion Criteria
- •Subjects whose psychotropic medications had been changed within 4 weeks prior to the entry or who had started psychotherapy within 3 months prior to the entry were excluded.
- •Subjects were also excluded if they were taking carbonic anhydrase inhibitors, carbamazepine, phenytoin, phenobarbital, valproic acid, evening primrose oil or oral contraceptives.
- •Other exclusion criteria were: history of substance use disorders within the 6 months prior to study, IQ \< or = 70, medical conditions causing weight loss (i.e., hyperthyroidism, diabetes mellitus type 1, malignancy) or that contra indicate treatment with topiramate (nephrolithiasis or glaucoma), history of non response or poor tolerance to topiramate in the past and history of non-adherence to medication treatment.
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered IndividualsAlcohol DependenceBinge EatingNCT00300742University of Virginia5
Completed
Phase 2
A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic MigraineBasilar MigraineNCT00158002Monarch Medical Research40
Completed
Phase 3
Topiramate and Severe ObesityObese Children and AdolescentsNCT02273804Assistance Publique - Hôpitaux de Paris18
Completed
Not Applicable
Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes MellitusObesityDiabetes Mellitus Type 2NCT00304603Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1,145
Completed
Phase 3
An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.Tourette SyndromeNCT00206336Baylor College of Medicine20